Ocuphire Pharma Price on November 14, 2023
OCUPDelisted Stock | USD 1.13 0.06 5.04% |
If you're considering investing in Ocuphire Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ocuphire Pharma stands at 1.13, as last reported on the 23rd of November, with the highest price reaching 1.20 and the lowest price hitting 1.10 during the day. Ocuphire Pharma maintains Sharpe Ratio (i.e., Efficiency) of -0.0551, which implies the firm had a -0.0551% return per unit of risk over the last 3 months. Ocuphire Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Ocuphire Pharma's Variance of 19.94, coefficient of variation of (595.44), and Risk Adjusted Performance of (0.12) to confirm the risk estimate we provide.
Ocuphire Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Ocuphire |
Sharpe Ratio = -0.0551
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | OCUP |
Estimated Market Risk
3.63 actual daily | 32 68% of assets are more volatile |
Expected Return
-0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Ocuphire Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ocuphire Pharma by adding Ocuphire Pharma to a well-diversified portfolio.
Related Headline
Reviva Pharmaceuticals Headline on 14th of November 2023
Acquisition by Funtleyder Leslie D of 8200 shares of Reviva ... by Funtleyder Leslie D
Filed transaction by Reviva Pharmaceuticals Ho director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Ocuphire Pharma Valuation on November 14, 2023
It is possible to determine the worth of Ocuphire Pharma on a given historical date. On November 14, 2023 Ocuphire was worth 2.98 at the beginning of the trading date compared to the closed value of 3.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ocuphire Pharma stock. Still, in general, we apply an absolute valuation method to find Ocuphire Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ocuphire Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ocuphire Pharma's related companies.
Open | High | Low | Close | Volume | |
2.90 | 3.02 | 2.74 | 2.88 | 133,113 | |
11/14/2023 | 2.98 | 3.25 | 2.85 | 3.21 | 275,206 |
3.25 | 3.27 | 3.07 | 3.15 | 143,373 |
Backtest Ocuphire Pharma | | | Ocuphire Pharma History | | | Ocuphire Pharma Valuation | Previous | Next |
Ocuphire Pharma Trading Date Momentum on November 14, 2023
On November 15 2023 Ocuphire Pharma was traded for 3.15 at the closing time. The top price for the day was 3.27 and the lowest listed price was 3.07 . The trading volume for the day was 143.4 K. The trading history from November 15, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.87% . The trading delta at closing time against the current closing price is 11.53% . |
Ocuphire Pharma Fundamentals Correlations and Trends
By evaluating Ocuphire Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ocuphire Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ocuphire financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ocuphire Pharma Stock history
Ocuphire Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ocuphire is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ocuphire Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ocuphire Pharma stock prices may prove useful in developing a viable investing in Ocuphire Pharma
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire Pharma, Inc. is headquartered in Farmington Hills, Michigan. Ocuphire Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people.
Ocuphire Pharma Stock Technical Analysis
Ocuphire Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Ocuphire Pharma Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Ocuphire Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ocuphire Pharma November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Ocuphire Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ocuphire Pharma shares will generate the highest return on investment. By undertsting and applying Ocuphire Pharma stock market strength indicators, traders can identify Ocuphire Pharma entry and exit signals to maximize returns
Ocuphire Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ocuphire Pharma's price direction in advance. Along with the technical and fundamental analysis of Ocuphire Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ocuphire to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.12) | |||
Jensen Alpha | (0.74) | |||
Total Risk Alpha | (1.46) | |||
Treynor Ratio | 5.87 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Ocuphire Stock
If you are still planning to invest in Ocuphire Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocuphire Pharma's history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |